A controlled breathing therapy that alternates between reduced and elevated oxygen concentrations to stimulate mitochondrial renewal, improve cellular energy production, and enhance overall metabolic function.
Intermittent Hypoxia-Hyperoxia Training (IHHT) is a non-invasive therapy in which the patient breathes alternating intervals of low-oxygen (hypoxic) and high-oxygen (hyperoxic) air through a face mask while resting comfortably. This simulates aspects of altitude training in a controlled medical setting.
The therapy targets mitochondria — the energy-producing organelles in every cell. Dysfunctional mitochondria, which accumulate with age and chronic illness, are selectively eliminated through a process called mitophagy, while the production of new, healthy mitochondria is stimulated.
During an IHHT session, the patient breathes through a mask connected to a device that precisely controls oxygen concentration. Hypoxic intervals (9-13% O2) lasting 3-5 minutes alternate with hyperoxic intervals (30-40% O2) of similar duration. This cycle is repeated for 30-40 minutes per session.
The hypoxic stimulus activates hypoxia-inducible factor (HIF) pathways, triggering mitophagy of damaged mitochondria. The subsequent hyperoxic phase promotes mitochondrial biogenesis through PGC-1alpha activation. Over a course of treatments, the net effect is an improvement in the overall quality and efficiency of the cellular mitochondrial population.
IHHT is prescribed based on metabolic testing results. Our physicians will determine whether this therapy is appropriate for your condition and treatment goals.
Intermittent hypoxia training has been studied in clinical trials for cardiovascular health, metabolic syndrome, and exercise performance. Published research in journals including the European Journal of Applied Physiology and Frontiers in Physiology supports its effects on mitochondrial function and metabolic parameters. The addition of hyperoxic intervals (IHHT vs. IHT alone) is a more recent development with growing clinical evidence. Contraindications include unstable angina, severe COPD, and acute infections.
Contact our medical team to discuss whether intermittent hypoxia-hyperoxia training may benefit your condition.
